Kurtz Ronald M MD
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Kurtz Ronald M MD. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| RXST | President & CEO | Option Exercise | 7,650 | $15.08 | $115,362 | Aug 9, 2024 |
| RXST | President & CEO | Option Exercise | 13,500 | $15.08 | $203,580 | Jul 11, 2024 |
| RXST | President & CEO | Sale | 40,000 | $60.15 | $2,406,000 | May 3, 2024 |
| RXST | President & CEO | Sale | 31,250 | $45.00 | $1,406,250 | Jan 8, 2024 |
| RXST | President & CEO | Sale | 22,500 | $41.09 | $924,525 | Dec 27, 2023 |
| RXST | President & CEO | Sale | 20,000 | $40.01 | $800,200 | Dec 14, 2023 |
| RXST | President & CEO | Award / Grant | 40,000 | $12.50 | $500,000 | Feb 10, 2023 |
| RXST | See Remarks | Purchase | 3,638 | $13.85 | $50,386 | Aug 3, 2021 |